Vectorious Medical Technologies, a Tel Aviv, Israel-based medical device company, closed a $5m financing round.
Backers included the RadBioMed incubator, which is owned jointly by Yehuda Zisapel and Prof. Nava Zisapel; private investors Zohar Gilon, Gur Muntzer and others; and the U.S.-based Global Cardiovascular Innovation Center (GCIC) of the Cleveland Clinic.
The company will use the proceeds for further development as needed to initiate first in-human trials in collaboration with senior cardiologists from America and Israel.
Led by Oren Goldstein, founder and CEO, Vectorious develops a cardiac monitoring system for patients suffering from congestive heart failure (CHF), which leverages technologies in the areas of miniature sensing and wireless communications to enable daily readings of left atrial pressure,
FinSMEs
26/05/2015